Lowenstein Sandler LLP has advised Celldex Therapeutics, Inc., and Wilmer Cutler Pickering Hale and Dorr has represented the underwriters. Celldex Therapeutics, Inc. (Nasdaq: CLDX) has announced…
Celldex Therapeutics Raises $345 Million in Public Offering of Common Stock

























